scholarly article | Q13442814 |
P50 | author | Harvey I Pass | Q51800337 |
P2093 | author name string | Anil Wali | |
James F Eliason | |||
Joseph F Cortese | |||
Ashok L Gowda | |||
Richard B Everson | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
P1104 | number of pages | 2 | |
P304 | page(s) | 521-522 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma | |
P478 | volume | 118 |
Q28395184 | DNA copy number gains in malignant pleural mesothelioma |
Q37400550 | Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity |
Q54538613 | Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma. |
Q33760654 | Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib |
Q37449036 | Future developments in the management of malignant pleural mesothelioma |
Q34293068 | Investigational approaches for mesothelioma |
Q37529848 | Malignant pleural mesothelioma: current treatments and emerging drugs. |
Q38019747 | Malignant pleural mesothelioma: from the bench to the bedside. |
Q43797861 | Mesothelioma: closer to the target? |
Q36889671 | Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma |
Q35042668 | New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials |
Q39377749 | Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors |
Q37873380 | Review on clinical trials of targeted treatments in malignant mesothelioma |
Q37260408 | Systemic treatments for mesothelioma: standard and novel |
Q37734455 | Translational therapies for malignant pleural mesothelioma. |
Q36755500 | Update on the molecular biology of malignant mesothelioma |
Search more.